Nandrolone decanoate treatment of post-menopausal osteoporosis for 2 years and effects of withdrawal

This publication has 20 references indexed in Scilit:

• Changes in soft tissue body composition and plasma lipid metabolism during nandrolone decanoate therapy in postmenopausal osteoporotic women
  Metabolism, 1989
• Measurement of the subcutaneous fat in the distal forearm by single photon absorptiometry
  Metabolism, 1989
• Measurement of lean body mass and total body fat using dual photon absorptiometry
  Metabolism, 1986
• Stanozolol in postmenopausal osteoporosis: Therapeutic efficacy and possible mechanisms of action
  Metabolism, 1983
• Decreased Risk of Fractures of the Hip and Lower Forearm with Postmenopausal Use of Estrogen
  New England Journal of Medicine, 1980
• Prevention of early postmenopausal bone loss: controlled 2‐year study in 315 normal females
  European Journal of Clinical Investigation, 1980
• POST-MENOPAUSAL $OElig;STROGENS PROTECT AGAINST FRACTURES OF HIP AND DISTAL RADIUS A Case-control Study
  The Lancet, 1979
• Effect of methandrostenolone on postmenopausal bone wasting as assessed by changes in total bone mineral mass
  Metabolism, 1977
• Recommended Methods for the Determination of Four Enzymes in Blood
  Scandinavian Journal of Clinical and Laboratory Investigation, 1974
• RELATION BETWEEN BONE MASS AND MUSCLE WEIGHT
  The Lancet, 1970